To circumvent this issue, we utilized mouse T-ALL cell lines derived from two P53/R26+/+ control, one P53/R26-Zeb2tg/+ and four P53/R26-Zeb2tg/+ and P53/R26-Zeb2tg/tg tumours. This evidence concerns the gene TP53 and acute lymphoblastic leukemia.